annual SGA:
$20.53B+$2.31B(+12.68%)Summary
- As of today (May 29, 2025), AZN annual SGA is $20.53 billion, with the most recent change of +$2.31 billion (+12.68%) on December 31, 2024.
- During the last 3 years, AZN annual SGA has risen by +$4.94 billion (+31.70%).
- AZN annual SGA is now at all-time high.
Performance
AZN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$4.63B-$926.00M(-16.68%)Summary
- As of today (May 29, 2025), AZN quarterly SGA is $4.63 billion, with the most recent change of -$926.00 million (-16.68%) on March 31, 2025.
- Over the past year, AZN quarterly SGA has dropped by -$3.00 million (-0.06%).
- AZN quarterly SGA is now -16.68% below its all-time high of $5.55 billion, reached on December 31, 2024.
Performance
AZN quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$8.35B(NaN%)Summary
- As of today (May 29, 2025), AZN TTM SGA is $8.35 billion
- Over the past year, AZN TTM SGA has dropped by -$11.84 billion (-58.65%).
- AZN TTM SGA is now -88.49% below its all-time high of $72.56 billion.
Performance
AZN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AZN Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +12.7% | -0.1% | -58.6% |
3 y3 years | +31.7% | -6.8% | -52.4% |
5 y5 years | +71.3% | +64.9% | -31.6% |
AZN Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +31.7% | -16.7% | +21.6% | at high | +227.9% |
5 y | 5-year | at high | +72.6% | -16.7% | +68.9% | -50.7% | +227.9% |
alltime | all time | at high | >+9999.0% | -16.7% | +2146.1% | -88.5% | +227.9% |
AZN Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $4.63B(-16.7%) | $20.53B(-0.0%) |
Dec 2024 | $20.53B(+12.7%) | $5.55B(+5.0%) | $20.53B(+0.2%) |
Sep 2024 | - | $5.29B(+4.5%) | $20.50B(+1.8%) |
Jun 2024 | - | $5.06B(+9.3%) | $20.14B(-0.3%) |
Mar 2024 | - | $4.63B(-16.1%) | $20.19B(+2.2%) |
Dec 2023 | $18.22B(+1.3%) | $5.52B(+11.9%) | $19.75B(+9.5%) |
Sep 2023 | - | $4.93B(-3.7%) | $18.05B(+3.0%) |
Jun 2023 | - | $5.12B(+22.0%) | $17.52B(+1.8%) |
Mar 2023 | - | $4.19B(+10.2%) | $17.21B(-4.3%) |
Dec 2022 | $17.98B(+15.4%) | $3.81B(-13.6%) | $17.98B(-7.0%) |
Sep 2022 | - | $4.40B(-8.5%) | $19.33B(+1.0%) |
Jun 2022 | - | $4.81B(-3.1%) | $19.14B(+9.2%) |
Mar 2022 | - | $4.96B(-3.6%) | $17.53B(+12.4%) |
Dec 2021 | $15.59B(+31.1%) | $5.15B(+22.4%) | $15.59B(+11.7%) |
Sep 2021 | - | $4.21B(+31.5%) | $13.96B(+11.0%) |
Jun 2021 | - | $3.20B(+5.7%) | $12.58B(+3.8%) |
Mar 2021 | - | $3.03B(-14.0%) | $12.12B(+1.9%) |
Dec 2020 | $11.90B(-0.7%) | $3.52B(+24.5%) | $11.90B(+3.8%) |
Sep 2020 | - | $2.83B(+3.3%) | $11.46B(-3.8%) |
Jun 2020 | - | $2.74B(-2.4%) | $11.91B(-2.3%) |
Mar 2020 | - | $2.81B(-9.0%) | $12.20B(+1.8%) |
Dec 2019 | $11.98B(+9.1%) | $3.08B(-6.2%) | $11.98B(-2.8%) |
Sep 2019 | - | $3.29B(+8.7%) | $12.33B(+7.1%) |
Jun 2019 | - | $3.02B(+16.7%) | $11.51B(+3.5%) |
Mar 2019 | - | $2.59B(-24.3%) | $11.12B(+0.5%) |
Dec 2018 | $10.98B(+4.2%) | $3.42B(+38.6%) | $11.07B(+9.0%) |
Sep 2018 | - | $2.47B(-6.3%) | $10.15B(-1.0%) |
Jun 2018 | - | $2.63B(+3.8%) | $10.25B(+2.0%) |
Mar 2018 | - | $2.54B(+1.3%) | $10.05B(+1.6%) |
Dec 2017 | $10.54B(+8.3%) | $2.50B(-2.6%) | $9.88B(+30.3%) |
Sep 2017 | - | $2.57B(+5.9%) | $7.59B(+1.3%) |
Jun 2017 | - | $2.43B(+2.2%) | $7.49B(-8.7%) |
Mar 2017 | - | $2.38B(+1053.9%) | $8.21B(-3.2%) |
Dec 2016 | $9.74B(-15.4%) | $206.00M(-91.7%) | $8.48B(-23.7%) |
Sep 2016 | - | $2.48B(-21.1%) | $11.10B(-2.5%) |
Jun 2016 | - | $3.14B(+18.7%) | $11.38B(+0.8%) |
Mar 2016 | - | $2.65B(-6.5%) | $11.29B(-2.0%) |
Dec 2015 | $11.52B(-13.6%) | $2.83B(+2.7%) | $11.52B(-6.6%) |
Sep 2015 | - | $2.76B(-9.6%) | $12.33B(-3.6%) |
Jun 2015 | - | $3.05B(+6.1%) | $12.79B(-0.7%) |
Mar 2015 | - | $2.88B(-21.1%) | $12.87B(+0.6%) |
Dec 2014 | $13.32B(+6.5%) | $3.64B(+13.2%) | $12.79B(-7.7%) |
Sep 2014 | - | $3.22B(+2.7%) | $13.87B(+4.8%) |
Jun 2014 | - | $3.13B(+12.0%) | $13.23B(+4.1%) |
Mar 2014 | - | $2.80B(-40.6%) | $12.71B(+1.6%) |
Dec 2013 | $12.51B(+23.2%) | $4.71B(+82.4%) | $12.51B(+18.6%) |
Sep 2013 | - | $2.58B(-1.3%) | $10.55B(+1.3%) |
Jun 2013 | - | $2.62B(+0.9%) | $10.41B(+1.9%) |
Mar 2013 | - | $2.60B(-5.6%) | $10.22B(+0.6%) |
Dec 2012 | $10.16B(-11.7%) | $2.75B(+12.2%) | $10.16B(-4.5%) |
Sep 2012 | - | $2.45B(+1.0%) | $10.64B(-2.6%) |
Jun 2012 | - | $2.42B(-4.4%) | $10.93B(-4.6%) |
Mar 2012 | - | $2.54B(-21.4%) | $11.46B(-0.4%) |
Dec 2011 | $11.51B(+6.7%) | $3.23B(+17.9%) | $11.51B(+5.7%) |
Sep 2011 | - | $2.74B(-7.4%) | $10.89B(-3.2%) |
Jun 2011 | - | $2.96B(+14.2%) | $11.25B(+3.9%) |
Mar 2011 | - | $2.59B(-0.8%) | $10.83B(+0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2010 | $10.78B(-7.3%) | $2.61B(-15.6%) | $10.78B(-8.1%) |
Sep 2010 | - | $3.09B(+21.9%) | $11.73B(+3.1%) |
Jun 2010 | - | $2.54B(-0.1%) | $11.37B(-3.1%) |
Mar 2010 | - | $2.54B(-28.6%) | $11.73B(+0.9%) |
Dec 2009 | $11.63B(+3.8%) | $3.56B(+30.0%) | $11.63B(+2.2%) |
Sep 2009 | - | $2.74B(-5.6%) | $11.38B(+2.7%) |
Jun 2009 | - | $2.90B(+18.8%) | $11.08B(+1.3%) |
Mar 2009 | - | $2.44B(-26.2%) | $10.94B(-2.4%) |
Dec 2008 | $11.20B(+5.6%) | $3.31B(+35.8%) | $11.20B(-0.6%) |
Sep 2008 | - | $2.43B(-11.8%) | $11.27B(-1.2%) |
Jun 2008 | - | $2.76B(+2.0%) | $11.40B(+3.3%) |
Mar 2008 | - | $2.71B(-19.7%) | $11.04B(+4.0%) |
Dec 2007 | $10.61B(+13.8%) | $3.37B(+31.1%) | $10.61B(+6.3%) |
Sep 2007 | - | $2.57B(+7.2%) | $9.98B(+4.1%) |
Jun 2007 | - | $2.40B(+5.2%) | $9.59B(+1.1%) |
Mar 2007 | - | $2.28B(-16.8%) | $9.48B(+1.7%) |
Dec 2006 | $9.32B(+4.7%) | $2.74B(+25.6%) | $9.32B(+1.3%) |
Sep 2006 | - | $2.18B(-4.8%) | $9.20B(+1.4%) |
Jun 2006 | - | $2.29B(+8.3%) | $9.07B(+0.7%) |
Mar 2006 | - | $2.12B(-19.1%) | $9.01B(+1.2%) |
Dec 2005 | $8.91B(+5.5%) | $2.61B(+27.1%) | $8.91B(+5.1%) |
Sep 2005 | - | $2.06B(-7.8%) | $8.47B(+0.5%) |
Jun 2005 | - | $2.23B(+11.1%) | $8.43B(+0.3%) |
Mar 2005 | - | $2.01B(-8.1%) | $8.41B(+0.0%) |
Dec 2004 | $8.45B(+11.8%) | $2.18B(+8.6%) | $8.40B(-4.0%) |
Sep 2004 | - | $2.01B(-8.8%) | $8.75B(+1.9%) |
Jun 2004 | - | $2.21B(+10.1%) | $8.59B(+7.0%) |
Mar 2004 | - | $2.00B(-20.9%) | $8.03B(+6.3%) |
Dec 2003 | $7.55B(+23.1%) | $2.53B(+36.8%) | $7.56B(+10.5%) |
Sep 2003 | - | $1.85B(+12.7%) | $6.83B(+7.2%) |
Jun 2003 | - | $1.64B(+7.5%) | $6.38B(+2.0%) |
Mar 2003 | - | $1.53B(-15.6%) | $6.25B(+1.9%) |
Dec 2002 | $6.14B(+10.6%) | $1.81B(+30.0%) | $6.14B(+5.8%) |
Sep 2002 | - | $1.39B(-8.3%) | $5.80B(+0.7%) |
Jun 2002 | - | $1.52B(+7.5%) | $5.76B(+2.7%) |
Mar 2002 | - | $1.41B(-4.2%) | $5.61B(+1.8%) |
Dec 2001 | $5.55B(+6091.9%) | $1.48B(+9.1%) | $5.51B(+36.5%) |
Sep 2001 | - | $1.35B(-1.2%) | $4.04B(+3.0%) |
Jun 2001 | - | $1.37B(+4.0%) | $3.92B(+2.9%) |
Mar 2001 | - | $1.32B(+6.7%) | $3.81B(-18.1%) |
Dec 2000 | $89.62M(-98.2%) | - | - |
Sep 2000 | - | $1.23B(-1.9%) | $4.65B(+0.9%) |
Jun 2000 | - | $1.26B(+3.4%) | $4.61B(-2.8%) |
Mar 2000 | - | $1.22B(+28.9%) | $4.74B(+34.5%) |
Dec 1999 | $4.92B(+24.9%) | $944.00M(-20.9%) | $3.53B(+36.6%) |
Sep 1999 | - | $1.19B(-14.1%) | $2.58B(+85.9%) |
Jun 1999 | - | $1.39B(+47.8%) | $1.39B(+47.8%) |
Dec 1998 | $3.94B(>+9900.0%) | - | - |
Jun 1998 | - | $939.50M(+36.1%) | $939.50M(+36.1%) |
Dec 1997 | $36.37M(-3.5%) | - | - |
Dec 1996 | $37.68M(-18.7%) | - | - |
Dec 1995 | $46.36M(-17.6%) | - | - |
Jun 1995 | - | $690.40M | $690.40M |
Dec 1994 | $56.28M(+8.7%) | - | - |
Dec 1993 | $51.77M(+6.7%) | - | - |
Dec 1992 | $48.53M(-3.9%) | - | - |
Dec 1991 | $50.52M(+4.8%) | - | - |
Dec 1990 | $48.22M | - | - |
FAQ
- What is AstraZeneca annual SGA?
- What is the all time high annual SGA for AstraZeneca?
- What is AstraZeneca annual SGA year-on-year change?
- What is AstraZeneca quarterly SGA?
- What is the all time high quarterly SGA for AstraZeneca?
- What is AstraZeneca quarterly SGA year-on-year change?
- What is AstraZeneca TTM SGA?
- What is the all time high TTM SGA for AstraZeneca?
- What is AstraZeneca TTM SGA year-on-year change?
What is AstraZeneca annual SGA?
The current annual SGA of AZN is $20.53B
What is the all time high annual SGA for AstraZeneca?
AstraZeneca all-time high annual SGA is $20.53B
What is AstraZeneca annual SGA year-on-year change?
Over the past year, AZN annual SGA has changed by +$2.31B (+12.68%)
What is AstraZeneca quarterly SGA?
The current quarterly SGA of AZN is $4.63B
What is the all time high quarterly SGA for AstraZeneca?
AstraZeneca all-time high quarterly SGA is $5.55B
What is AstraZeneca quarterly SGA year-on-year change?
Over the past year, AZN quarterly SGA has changed by -$3.00M (-0.06%)
What is AstraZeneca TTM SGA?
The current TTM SGA of AZN is $8.35B
What is the all time high TTM SGA for AstraZeneca?
AstraZeneca all-time high TTM SGA is $72.56B
What is AstraZeneca TTM SGA year-on-year change?
Over the past year, AZN TTM SGA has changed by -$11.84B (-58.65%)